[ad_1]
BREAKING NEWS: FDA will decide on whether to fully approve Pfizer’s COVID-19 vaccine by January 2022
- The U.S. Food and Drug Administration (FDA) goal data to decide on full approval of Pfizer-BioNTech’s COVID-19 vaccine for ages 16 and older is January 2022
- If approved, it will be the first fully approved coronavirus shot in America
- Currently, the vaccine is only authorized for emergency use in Americans aged 12 and up
The U.S. Food and Drug Administration (FDA) will decide on full approval of Pfizer-BioNTech’s COVID-19 vaccine for those aged 16 and older no later than early next year.
Currently, the shot is only authorized for emergency use in Americans aged 12 and up.
According a press release from the two companies on Friday, the agency’s goal date for a decision is by January 2022.
If approved, the vaccine will be the first fully approved COVID-19 shot and could help ease vaccine hesitancy due to longer-term data required for an FDA approval.
The U.S. Food and Drug Administration (FDA) goal data to decide on full approval of Pfizer-BioNTech’s COVID-19 vaccine for ages 16 and older is January 2022 (file image)
This is a breaking new story and will be updated.
Advertisement
[ad_2]
